Clinical Trial Update: Blood Detection of EGFR Mutation For Iressa Treatment [NA]

View source ↗

Summary

This clinical trial update covers blood-based detection of EGFR mutations to guide Iressa (gefitinib) therapy in lung adenocarcinoma. The trial status is listed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma

Drugs mentioned

• Iressa (gefitinib)

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Lung Adenocarcinoma | NA | Status: UNKNOWN